genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 5.10
+0.04 (0.79%)
Last updated: Feb 13, 2026, 11:25 AM CET
genXone Market Cap
genXone has a market cap or net worth of 16.72 million as of February 13, 2026. Its market cap has decreased by -13.65% in one year.
Market Cap
16.72M
Enterprise Value
12.95M
Revenue
2.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 16.72M, a decrease of -88.20%. That is a compound annual growth rate of -32.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 15.37M | 16.54% |
| Dec 30, 2025 | 13.19M | -35.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.08B |
| NEUCA | 3.49B |
| Synektik Spólka Akcyjna | 2.54B |
| Voxel | 1.44B |
| Medicofarma Biotech | 31.81M |
| Nestmedic | 27.81M |
| InventionMed | 21.80M |
| Stem Cells Spin | 16.87M |